Evidence map›Paper›PMID 40584686›Full record

ArticleThe World Allergy Organization journal2025

How accurate are ChatGPT-4 responses in chronic urticaria? A critical analysis with information quality metrics.

Ivan Cherrez-Ojeda, Marco Faytong-Haro, Patricio Alvarez-Muñoz, José Ignacio Larco, Erika de Arruda Chaves, Isabel Rojo, Carol Vivian Moncayo, German D Ramon, Gabriela Rodas-Valero, Emek Kocatürk and 2 more

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ivan Cherrez-OjedaUniversidad Espíritu Santo, Samborondon, Ecuador.
Marco Faytong-HaroRespiralab Research Group, Guayaquil, Ecuador.
Patricio Alvarez-MuñozUniversidad Estatal de Milagro, Cdla. Universitaria "Dr. Rómulo Minchala Murillo" - Km. 1.5 Vía Milagro - Virgen de Fátima, Milagro, Guayas 091050, Ecuador.
José Ignacio LarcoAllergy Department, Clinica San Felipe, Lima, Peru.
Erika de Arruda ChavesUnidad de Alergia e Inmunología Clínica, Clínica Anglo-Americana, Lima, Peru.
Isabel RojoAllergy Service, Juarez Hospital, Mexico City, Mexico.
Carol Vivian MoncayoAllergy Service, Hospital Juarez de Mexico, Mexico.
German D RamonInstituto de Alergia e Inmunología del Sur, Bahia Blanca, Argentina.
Gabriela Rodas-ValeroUniversidad Espíritu Santo, Samborondon, Ecuador.
Emek KocatürkInstitute of Allergology, Charité Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Giselle S MosnaimDivision of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, IL, USA.
Karla Robles-VelascoUniversidad Espíritu Santo, Samborondon, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing use of artificial intelligence (AI) in healthcare, especially in delivering medical information, prompts concerns over the reliability and accuracy of AI-generated responses. This study evaluates the quality, reliability, and readability of ChatGPT-4 responses for chronic urticaria (CU) care, considering the potential implications of inaccurate medical information. Objective: The goal of the study was to assess the quality, reliability, and readability of ChatGPT-4 responses to inquiries on CU management in accordance with international guidelines, utilizing validated metrics to evaluate the effectiveness of ChatGPT-4 as a resource for medical information acquisition. Methods: Twenty-four questions were derived from the EAACI/GA Results: Categories A and C exhibited insufficient reliability according to JAMA, with median scores of 1 and 0, respectively. Category B exhibited a low reliability score (median 2, interquartile range 2). The information quality from category C questions was satisfactory (median 51.5, IQR 12.5). All 3 groups exhibited confusing readability levels according to the Flesch assessment. Limitations: The study's limitations encompass the emphasis on CU, possible bias in question selection, the use of particular instruments such as DISCERN, JAMA, and Flesch, as well as reliance on expert opinion for assessment. Conclusion: ChatGPT-4 demonstrates potential for producing medical content; nonetheless, its reliability is shaky underscoring the necessity for caution and confirmation when employing AI-generated medical information, especially in the management of CU.

Indexed as

Artificial intelligenceChronic urticariaGenerative artificial intelligence

Identifiers

PMID40584686
PMCPMC12206104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.